These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
209 related articles for article (PubMed ID: 30685472)
41. Selective mode of action of plumbagin through BRCA1 deficient breast cancer stem cells. Somasundaram V; Hemalatha SK; Pal K; Sinha S; Nair AS; Mukhopadhyay D; Srinivas P BMC Cancer; 2016 May; 16():336. PubMed ID: 27229859 [TBL] [Abstract][Full Text] [Related]
42. Plumbagin induces growth inhibition of human glioma cells by downregulating the expression and activity of FOXM1. Liu X; Cai W; Niu M; Chong Y; Liu H; Hu W; Wang D; Gao S; Shi Q; Hu J; Zhou X; Yu R J Neurooncol; 2015 Feb; 121(3):469-77. PubMed ID: 25528634 [TBL] [Abstract][Full Text] [Related]
43. Plumbagin suppresses the human large cell lung cancer cell lines by inhibiting IL-6/STAT3 signaling in vitro. Yu T; Xu YY; Zhang YY; Li KY; Shao Y; Liu G Int Immunopharmacol; 2018 Feb; 55():290-296. PubMed ID: 29294439 [TBL] [Abstract][Full Text] [Related]
44. Plumbagin induces cell death through a copper-redox cycle mechanism in human cancer cells. Nazeem S; Azmi AS; Hanif S; Ahmad A; Mohammad RM; Hadi SM; Kumar KS Mutagenesis; 2009 Sep; 24(5):413-8. PubMed ID: 19505895 [TBL] [Abstract][Full Text] [Related]
45. Targeting Pancreatic Cancer with Novel Plumbagin Derivatives: Design, Synthesis, Molecular Mechanism, Awale S; Baba H; Phan ND; Kim MJ; Maneenet J; Sawaki K; Kanda M; Okumura T; Fujii T; Okada T; Maruyama T; Okada T; Toyooka N J Med Chem; 2023 Jun; 66(12):8054-8065. PubMed ID: 37257133 [TBL] [Abstract][Full Text] [Related]
46. Plumbagin inhibits the proliferation of nasopharyngeal carcinoma 6-10B cells by upregulation of reactive oxygen species. Li B; Gu X; Wu M; Zhao Y; Yang J; Feng L; Gou J; Chen L; Li T; Li L; Wang L; Zhu L; Zhang K Anticancer Drugs; 2018 Oct; 29(9):890-897. PubMed ID: 30119131 [TBL] [Abstract][Full Text] [Related]
47. Plumbagin induces apoptosis in lymphoma cells via oxidative stress mediated glutathionylation and inhibition of mitogen-activated protein kinase phosphatases (MKP1/2). Checker R; Gambhir L; Sharma D; Kumar M; Sandur SK Cancer Lett; 2015 Feb; 357(1):265-278. PubMed ID: 25444924 [TBL] [Abstract][Full Text] [Related]
48. Ferrocene and (arene)ruthenium(II) complexes of the natural anticancer naphthoquinone plumbagin with enhanced efficacy against resistant cancer cells and a genuine mode of action. Spoerlein-Guettler C; Mahal K; Schobert R; Biersack B J Inorg Biochem; 2014 Sep; 138():64-72. PubMed ID: 24907976 [TBL] [Abstract][Full Text] [Related]
49. Anticancer mechanism of plumbagin, a natural compound, on non-small cell lung cancer cells. Gomathinayagam R; Sowmyalakshmi S; Mardhatillah F; Kumar R; Akbarsha MA; Damodaran C Anticancer Res; 2008; 28(2A):785-92. PubMed ID: 18507021 [TBL] [Abstract][Full Text] [Related]
50. Plumbagin reduces chronic lymphocytic leukemia cell survival by downregulation of Bcl-2 but upregulation of the Bax protein level. Fu C; Gong Y; Shi X; Sun Z; Niu M; Sang W; Xu L; Zhu F; Wang Y; Xu K Oncol Rep; 2016 Sep; 36(3):1605-11. PubMed ID: 27461100 [TBL] [Abstract][Full Text] [Related]
51. Elucidation of the effect of plumbagin on the metastatic potential of B16F10 murine melanoma cells via MAPK signalling pathway. Alem FZ; Bejaoui M; Villareal MO; Rhourri-Frih B; Isoda H Exp Dermatol; 2020 Apr; 29(4):427-435. PubMed ID: 32012353 [TBL] [Abstract][Full Text] [Related]
52. Plumbagin-induced apoptosis in human prostate cancer cells is associated with modulation of cellular redox status and generation of reactive oxygen species. Powolny AA; Singh SV Pharm Res; 2008 Sep; 25(9):2171-80. PubMed ID: 18213451 [TBL] [Abstract][Full Text] [Related]
53. Antitumorigenic effect of plumbagin by induction of SH2-containing protein tyrosine phosphatase 1 in human gastric cancer cells. Joo MK; Park JJ; Kim SH; Yoo HS; Lee BJ; Chun HJ; Lee SW; Bak YT Int J Oncol; 2015; 46(6):2380-8. PubMed ID: 25815436 [TBL] [Abstract][Full Text] [Related]
54. Cytotoxicity and apoptosis induced by a plumbagin derivative in estrogen positive MCF-7 breast cancer cells. Sagar S; Esau L; Moosa B; Khashab NM; Bajic VB; Kaur M Anticancer Agents Med Chem; 2014 Jan; 14(1):170-80. PubMed ID: 24164046 [TBL] [Abstract][Full Text] [Related]
55. Caging of plumbagin on silver nanoparticles imparts selectivity and sensitivity to plumbagin for targeted cancer cell apoptosis. Duraipandy N; Lakra R; Kunnavakkam Vinjimur S; Samanta D; K PS; Kiran MS Metallomics; 2014 Nov; 6(11):2025-33. PubMed ID: 25188862 [TBL] [Abstract][Full Text] [Related]
56. Plumbagin Inhibits Prostate Carcinogenesis in Intact and Castrated PTEN Knockout Mice via Targeting PKCĪµ, Stat3, and Epithelial-to-Mesenchymal Transition Markers. Hafeez BB; Fischer JW; Singh A; Zhong W; Mustafa A; Meske L; Sheikhani MO; Verma AK Cancer Prev Res (Phila); 2015 May; 8(5):375-86. PubMed ID: 25627799 [TBL] [Abstract][Full Text] [Related]
57. Plumbagin sensitizes breast cancer cells to tamoxifen-induced cell death through GRP78 inhibition and Bik upregulation. Kawiak A; Domachowska A; Jaworska A; Lojkowska E Sci Rep; 2017 Mar; 7():43781. PubMed ID: 28287102 [TBL] [Abstract][Full Text] [Related]
58. Plumbagin exerts an immunosuppressive effect on human T-cell acute lymphoblastic leukemia MOLT-4 cells. Bae KJ; Lee Y; Kim SA; Kim J Biochem Biophys Res Commun; 2016 Apr; 473(1):272-277. PubMed ID: 27018383 [TBL] [Abstract][Full Text] [Related]
59. Shikonin inhibits prostate cancer cells metastasis by reducing matrix metalloproteinase-2/-9 expression via AKT/mTOR and ROS/ERK1/2 pathways. Chen Y; Zheng L; Liu J; Zhou Z; Cao X; Lv X; Chen F Int Immunopharmacol; 2014 Aug; 21(2):447-55. PubMed ID: 24905636 [TBL] [Abstract][Full Text] [Related]
60. Plumbagin induces ROS-mediated apoptosis in human promyelocytic leukemia cells in vivo. Xu KH; Lu DP Leuk Res; 2010 May; 34(5):658-65. PubMed ID: 19748668 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]